Wuhan Xinsheng Biotechnology Co., Ltd. was founded in Wuhan Optical Valley Bio-City in March 2018. The company's production base is located by the beautiful Liangzi Lake and was completed and put into use in March 2019. It is mainly used for the production of microfluidic detection instruments and microfluidic biochemical immune detection reagents.

      The company has established an international cutting-edge R & D team, members have more than 10 years of medical industry R & D management experience, with a graduate degree from Huazhong University of Science and Technology, Chinese Academy of Sciences. The company has established cooperative relations with wuhan National Optoelectronics Laboratory, Wuhan University School of Basic Medicine, Chinese Academy of Sciences shenzhen Institute of Advanced Technology, Huazhong University of Science and Technology Industrial Technology Research Institute and other institutions, and constantly improve the team's self-research and development ability.

      Core creatures based on the in vitro diagnostic field, using international advanced microfluidic technology research and development for the situation of biochemical, immune diagnostic kits and microfluidic testing instrument, widely applicable to all kinds of biochemical tests and clinical diseases such as tumor immune detection and inspection, can also be used in biological medicine, food safety and environmental testing. After its establishment, Xinsheng participated in the 2018 China Innovation and Entrepreneurship Competition and won the first place in the Biomedical industry competition of Hubei Province, and participated in the national finals on behalf of Hubei Province.

      In 2019, Xinsheng entered the database of technology-based small and medium-sized enterprises of the Ministry of Science and Technology and won the title of "New Fourth Army for Entrepreneurship" in East Lake High-tech Zone.

      In 2020, it was identified as a national high-tech enterprise and selected into the "3551" Entrepreneurship Talent Plan of East Lake High-tech. In 2021, we obtained the second-class medical device registration certificate -- BI50 automatic Biochemical analyzer (based on microfluidic technology), and established practical business cooperation with a number of listed companies.